Tuberculosis Surveillance in Japan - Insights from 2019 Report
Explore the latest findings from the 2019 Tuberculosis Surveillance Report in Japan, including data on pulmonary and extra-pulmonary tuberculosis cases, clinically and bacteriologically confirmed instances, and insights into trends regarding rifampicin resistance and multi-drug resistance. Gain valuable information on the status of tuberculosis in Japan and its comparison with countries like China, Indonesia, Nepal, the Philippines, and Vietnam.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
TUBERCULOSIS IN JAPAN Annual Report - 2019 T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
PTB = pulmonary tuberculosis, EPTB = extra-pulmonary tuberculosis Clin = clinically confirmed, bac = bacteriologically confirmed T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
CHN= China, IDN= Indonesia, , NPL= Nepal, PHL= the Philippines,, VNM= Vietnam T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
Number Proportion T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
Bar = number, line = proportion, RR = rifampicin resistance, MDR = multi-drug resistance T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
Bar = number, line = proportion, INH= isoniazid T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA Bar = number, line = proportion, INH = isoniazid J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
T u b e r c u l o s i s S u r v e i l l a n c e Center-RIT/JATA J a p a n
